ArticleComputational and structural biotechnology journal2025
Unsupervised cell line embedding using pairwise drug response correlation.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- KG-DFI: A Prediction of Drug-Food Interactions Based on Knowledge Graph Embedding.Computational and structural biotechnology journal · 2026Article
- Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screens.PloS one · 2026Article
- HMCN1 as a conserved biomarker of epithelial-mesenchymal transition: a cross-cancer analysis.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human cell line models are essential for understanding diseases and cellular functions. They are particularly emphasized in drug discovery because these models enable the systematic screening of chemical compounds and their effects. However, the heterogeneity in measurement techniques and the fragmented characterization of cell lines in chemical screening and omics data pose significant challenges to their optimal utilization. To address this, we introduce an unsupervised deep learning model based on contrastive learning that integrates heterogeneous drug response screening data into a unified cell line embedding. Utilizing the resulting embedding enhances the performance of drug-cell line-related downstream machine learning tasks to varying degrees. We used drug response data from 1,136 cell lines to train an embedding model and subsequently embedded 537 additional cell lines that were not included in the training, thereby completing the full set of 1,673 cancer cell lines from the Cancer Dependency Map (DepMap) that have corresponding gene expression data. We demonstrate that incorporating the embedding into various drug response-related tasks improves machine learning performance, including predicting drug synergy and drug response in cell lines. Furthermore, we applied SHapley additive explanations (SHAP) to identify genes with significant contributions to the embedding and found that these genes are strongly associated with drug resistance of various cancers and multiple types of cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.